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Abstract―Microbial contamination, instability in production 
yields and cell lines are the challenges that must be faced by any 
pharmaceutical biotechnology industry when conducting cell 
culture as one of the stages of its production process. In the past, 
Company X has experienced twice contamination cases during 
cell culture process for its recombinant protein products. As a 
result, Company X suffered financial lossess at approximately 
3.05 billion rupiah and resulted in disruption of the stock of 
recombinant protein drug which are the active pharmaceutical 
ingredient for most of injection products. Therefore, an effective 
mitigation strategies are needed to manage any potential risks 
in the cell culture process. This study aims to design a risk 
mitigation strategy for risk in cell culture process by using 
House of Risk (HOR) method. There are two HOR matrices 
used in this study. HOR1 is used to determine which risk agents 
should be prioritized for prevention. In HOR2, several effective 
risk management strategies will be chosen. There are 40 risks 
events and 31 risk agents identified. Based on risk assessment 
results and applying Pareto Chart analysis there are two risk 
agents selected. Five proactive actions to mitigate these risks are 
proposed. They are training and personnel qualification 
program periodically, changing workflow become more efficient 
and convenient, more detailed revision of related documents, 
changing manual process to semi-automatic process gradually 
and additional person on each team as a verifier for double-
checking. 
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I. INTRODUCTION 
HE BIOTECHNOLOGY industry has grown 
significantly in recent years and continues to grow 
rapidly. Experts predict that new protein therapeutics are 
starting to enter the marketplace, with the first wave of 
protein drugs, antibody groups and peptide drugs expected to 
enter later in the next 10-20 years [1]. This rapid growth in 
protein therapeutics has been led by a diverse range of 
products produced in animal cell culture. The increasing 
demand for therapeutic protein products from animal cell 
cultures has resulted in the development of animal cell culture 
processes on a large scale with more efficient and reliable 
processes [2]. 
Company X is one of manufacturing company engaged in 
pharmaceutical biotechnology in Indonesia that produces 
recombinant protein as a drug subtances using animal cell 
culture. Some challenges that must be faced by using animal 
cell culture are controling product quality while maximizing 
productivity, controlling carbon dioxide concentration in the 
process, and minimizing the risk of contamination during the 
manufacturing process as well as from raw materials [1]. 
Some limitations or deficiencies that exist in the animal cell 
culture process, such as the need of a reliable and experienced 
operator in handling cell culture, the amount of target protein 
produced in the cell culture process is very small when 
compared to the amount of material used, the cell growth 
problems also affects the results of the target protein 
produced, the last is the variability product result from the 
continuous cell line [3]. Contamination in the cell culture 
process also one of challenge in the animal cell culture 
process and it is one of the biggest problems faced by 
Company X which resulted in a total loss of 3,05 billion 
rupiah in 2019. This also has an impact on the disruption of 
the stock of recombinant protein drug subtances in Company 
X which is an active pharmaceutical ingredient for major 
injection products. Contamination in the animal cell culture 
is the most frequently encountered and critical risk. 
Contamination in the animal cell culture process can caused 
by microorganisms or viruses. It can arise due to various 
reasons such as personnel errors, inadequate aseptic 
protocols, failures in the sterilization process, failure of 
equipment integrity, as well as the use of new materials that 
are resistant to inactivation or removal procedures [4]. 
Based on the statement that has been described, this 
research raises the problem about development House of Risk 
(HOR) method in the biopharmaceutical company especially 
in the animal cell culture of protein recombinant production 
process. The house of risk (HOR) developed by [5] was 
chosen to select a set of proactive actions deemed cost-
effective in managing risk in Company X. The HOR method 
is a method that focuses on formulating strategies for 
preventive, reduction and handling some of risk agents that 
potentially lead to more than one risk. The HOR method 
mostly has been used to analyze  risks in the supply chain 
context such as managing risk for Tuna supply chain as 
reported in [6]. The method also has been used manage risk in 
new product development process for fashion industry [7] and 
risk mitigation for project Gempol-Pasuruan highway project 
[8]. Implementation of risk management is important to 
control the risks occur which can threaten company business 
continuity. 
This study is aimed to identify and map the risks in the in 
the animal cell culture of protein recombinant production 
process. The model of HOR consisting of two steps, the first 
step (HOR1) was conducted by identifying all risk events and 
risk agents, then measured the severity of risk event and 
occurrences of risk agent, determine the relation between risk 
event and risk agent to calculate the Aggregate Risk Priority 
(ARP) value. The second step (HOR2) is intended to 
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formulate and prioritize the proactive action for risk handling 
to formulate risk control strategy recomendation for 
Company X. 
II.  METHOD 
This study examines animal cell culture of protein 
recombinant production process in the biopharmaceutical 
company using House of Risk (HOR) method. Originally 
House of Risk is aimed at managing risk in supply chain 
processess context, therefore all activities are mapped based 
on Supply Chain Operations Reference (SCOR) model, 
which are Plan, Source, Make, Deliver, and Return. But in 
this study all the cell culture steps of protein recombinant 
production process are catagorized and mapped based on 
internal company documents such as batch record. The steps 
Table 1. 
House of Risk 1 Model 
Process Risk Event (Ei) Risk Agent (Aj) Severity A1 A2 A3 A4 Aj 
1st Culture 
E1 R1         S1 
E2   R2       S2 
E3     R3     S3 
2nd Culture 
E4       R4   S4 
E5         R5 S5 
E6       R6   S6 
Main Culture 
E7     R7     S7 
E8   R8       S8 
E9 R9         S9 
Harvest and 
Filtration 
E10   R10       S10 
E11     R11     S11 
Ei         Rj Si 
Occurance O1 O2 O3 O4 Oj 
  ARPj ARP1 ARP2 ARP3 ARP4 ARPj 
Rank R1 R2 R3 R4 Rj 
 
Table 2. 
House of Risk 2 Model 
Risk Agent (Aj)  Proactive Action (PA) ARPj  PA1 PA2 PA3 PA4 PAk 
A1  E1         ARP1 
A2    E2       ARP2 
A3      E3     ARP3 
A4        E4   ARP4 





TE1 TE2 TE3 TE4 TEk   
Degree of 
Difficulty (Dk) 





ETD1 ETD2 ETD3 ETD4 ETDk   
Rank of Priority 
(R) 
 R1 R2 R3 R4 Rk   
 
Figure 1. Cell Culture Process Mapping in Company X. 
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of  cell culture of protein recombinant production process are 
divided into four steps, which are 1st Culture, 2nd Culture, 
Main Culture also Harvest & Filtration step. After activities 
in the process are mapped, next step is identify the risk event 
and risk agent by doing direct observation and also 
brainstorming using focus group discussion, the data will be 
validated by interviewing company internal stakeholder. The 
data are collected from January 2019 until February 2020. 
HOR is a combination between FMEA (Failure Mode and 
Effect Analysis) and HOQ (House of Quality) models. HOR 
method consists of two matrixes (steps) which are HOR1 and 
HOR2. 
HOR1 is used to determine which risk agents are to be 
given priority for preventive actions. The steps as follows : 
a. Identify risk events that could happen in cell culture of 
protein recombinant production process. In HOR1 
model shown in Table 1, the risk events are put in the 
left column, represented as Ei. 
b. Assess the impact (severity) of such risk event if 
happened. We use a 1-5 scale where 5 represents 
extremely severe or catastrophic impact. The severity of 
each risk event is put in the right column of Table 1, 
indicated as Si.\ 
c. Identify risk agents and assess the likelihood of 
occurrence of each risk agent. Here, a scale of 1-5 is also 
applied where 1 means almost never occurred and a 
value of 5 means almost certain to happen. The risk 
agents (Aj) are placed on top row of the table and the 
associated occurrence is on the bottom row, notated as 
Oj. 
d. Develop a relationship matrix, i.e. relationship between 
each risk agent and each risk event, Rij {0, 1, 3, 9} 
where 0 represents no relation and 1, 3, and 9 represent, 
respectively, low, moderate, and high relations.  
e. Calculate the Aggregate Risk Potential of agent j (ARPj) 
which is determined as the product of the likelihood of 
occurrence of the risk agent j and the aggregate impacts 
generated by the risk events caused by the risk agent j 
as in equation (1) above. 
Table 3. 
Risk Event and its Severity level in Cell Culture Process 
Code Risk Event Severity 
E1 Room not Cleaned Yet 1 
E2 Room temperature does not meet the requirements. 4 
E3 Relative Humidity (RH) room does not meet the requirements. 4 
E4 Differential Pressure (DP) room does not meet the requirements. 4 
E5 Environmental microbial monitoring does not meet the requirements. 4 
E6 Equipment not cleaned yet. 4 
E7 Filter integrity test results do not meet the requirements. 4 
E8 Failure of container and equipment sterilization. 4 
E9 Sterile material exposed to dirty air. 5 
E10 Conductivity of water does not meet the requirements. 4 
E11 Water endotoxin does not meet the requirements 4 
E12 The water microbial limit does not meet the requirements. 5 
E13 Incorrect of weighing material amount 4 
E14 An error occurred while adjust pH 3 
E15 Contaminated material. 5 
E16 Personnel microbial monitoring does not meet requirements. 5 
E17 Hose connection leaks 3 
E18 Many materials are wasted during filtration. 2 
E19 Error in setting equipment 2 
E20 Equipment failed to operate 3 
E21 Equipment temperature does not meet the requirements/not achieved 2 
E22 The CO2 levels of equipment do not meet the requirements. 3 
E23 The quantity of the prepared material is inadequate. 4 
E24 The media is exposed to outside air for a long time. 5 
E25 Microbial contamination 5 
E26 Media spill during transfer 4 
E27 Error in taking WCB (Working Cell Bank) 4 
E28 WCB in not good condition 4 
E29 WCB thawing time is too long 3 
E30 Many cells are dead/wasted. 4 
E31 Cell calculation error. 4 
E32 Number/growth of cells does not meet requirements. 4 
E33 Cell resistance does not meet the requirements. 4 
E34 Microbial contamination during incubation process. 4 
E35 Number of cells not divided homogen. 3 
E36 Equipment speed does not meet the requirements/not achieved. 3 
E37 Leak on Flexboy. 4 
E38 Auto dispenser hangs. 3 
E39 Operator experiences fatigue. 4 
E40 Equipment is not cleaned properly. 4 
 
Table 4. 
Risk Agents and its Occurence level in Cell Culture Process 
Code Risk Agent Occurence 
A1 Operator disobedience from procedure 4 
A2 Problems on AHU (Air Handling Unit) 2 
A3 Boiler problems 2 
A4 There are rooms that are not closed properly 2 
A5 Sampling Errors 3 
A6 Inadequate aseptic protocols 3 
A7 Room overload 5 
A8 Filter leak 2 
A9 Clogged filters 2 
A10 Pure Steam Generator (PSG) problem 2 
A11 Error in setting equipment 2 
A12 Overload equipment 3 
A13 Leak on the outer packaging material 2 
A14 Inadequate procedures 4 
A15 Problems in water treatment (WT) 2 
A16 Error in reading instrument 2 
A17 Analytical error 2 
A18 Leak in heat exchanger (HE) 4 
A19 There is no crosscheck procedure 3 
A20 Unqualified Operator 3 
A21 There is no testing for incoming materials 4 
A22 Material exposed to dirty air for a long time 3 
A23 Error in handling material by operator 4 
A24 Filter capacity too large 3 
A25 Amount of filtered material is too small 3 
A26 Broken / not good condition equipment 2 
A27 Difference with ambient temperature too far 2 
A28 CO2 Generator / Line problem 2 
A29 Inappropriate storage temperature 1 
A30 Insufficient of operator 5 
A31 Operators work manually and for a long time 5 
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𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 = 𝑂𝑂𝐴𝐴 × ∑𝑆𝑆𝑆𝑆𝐴𝐴𝑆𝑆𝐴𝐴          (1) f. Rank risk agents according to their aggregate risk 
potentials in a descending order. 





A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 A13 A14 A15 
E1 9                             1 
E2   9 9                         4 
E3   9 9                         4 
E4   9   3                       4 
E5   9     3 9 9                 4 
E6 9                             4 
E7 1             9 9             4 
E8                   9 3 1       4 
E9                         9 1   5 
E10         3                   9 4 
E11         3                   9 4 
E12         3                   9 5 
E13                           3   4 
E14                           3   3 
E15                               5 
E16         3 9                   5 
E17                           3   3 
E18                               2 
E19                           9   2 
E20                     3         3 
E21                     3         2 
E22                     3         3 
E23                           9   4 
E24           9                   5 
E25           9             9     5 
E26                           9   4 
E27                           9   4 
E28                           3   4 
E29                           9   3 
E30                               4 
E31                           1   4 
E32                               4 
E33                               4 
E34           9                   4 
E35                               3 
E36                     3         3 
E37                               4 
E38                     3         3 
E39                               4 
E40 9                             4 
Oj 4 2 2 2 3 3 5 2 2 2 2 3 2 4 2   
ARP 340 288 144 24 198 621 180 72 72 72 108 12 180 816 234   
R k 5 6 17 29 10 3 11 21 22 23 19 30 12 2 8   
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HOR2 is used to give priority to those actions considered 
effective but with reasonable money and resource 
commitments. The steps as follows : 
a. Select a number of risk agents with high-priority rank, 
possibly using Pareto analysis of the ARPj, to be dealt 
with in the second HOR. Those selected will be placed in 
the left side of HOR2 as depicted in Table 2. The 
corresponding ARPj values are put in the right column. 
b. Identify actions considered relevant for preventing the 
risk agents, one risk agent could be tackled with more than 
one actions and one action could simultaneously reduce 
the likelihood of occurrence of more than one risk agent. 
The actions are put on the top row in Table 2. 
c. Determine the relationship between each preventive 
action and each risk agent. The values could be {0,1,3,9} 
where 0 represents no relation and 1, 3, and 9 represent 
respectively, low, moderate and high relations between 
action k and agent j. This relationship (Ejk) could be 
considered as the degree of effectiveness of action k in 
reducing the likelihood of occurrence of risk agent j. 
d. Calculate the total effectiveness of each action as follows: 
     𝑇𝑇𝑇𝑇𝑇𝑇 = ∑𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 × 𝑇𝑇𝐴𝐴𝑇𝑇∀𝑇𝑇         (2) 
e. Assess the degree of difficulties in performing each action 
represented as Dk, and put those values in a row below 
the total effectiveness. The degree of difficulties, which 
can be represented by a scale should reflect the fund and 
other resources needed in doing the action.  
f. Calculate the total effectiveness to difficulty ratio.  
     𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇 = 𝑇𝑇𝑇𝑇𝑇𝑇
𝐷𝐷𝑇𝑇
           (3) 
g. Assign rank of priority to each action (Rk) where Rank 1 
is given to the action with the highest ETDk. 
III. RESULT AND DISCUSSION 
A. Process Activity Mapping 
Cell culture process in Company X consists of four main 
steps which are 1st Culture, 2nd Culture, Main Culture also 
Harvest & Filtration step as described in Figure 1. 
B. Risk Identification and Analysis 
Risk identification data was colected from brainstorming 
using focus group discussion and direct observation by expert 
team such as QA, QC and production manager, engineering 
supervisor. The data was validated by interviewing company 
internal stakeholder such as production manager, culture 
supervisor and also senior operator from culture part. Risk 
event and severity described in Table 3. There are 31 risk 
agents were identified in this step and the occurence was 
determined in Table 4. 
C. Risk Evaluation 
The risk analysis consists of identifying risk agents by 
using ARP scoring through HOR1. ARP assessment in HOR 
1 aims to gain risk agent ranking in the process of risk 
mitigation. ARP score is obtained by multiplying the value of 
risk severity, likelihood or probability risk events, and the 
value of relation between risk agent and risk event. 
Calculation of ARP of each risk agent using HOR1 matrix 
described in Table 5. Pareto Charts was used to determine 
priority of risk agent. Result of Pareto Chart described in 
Figure 2. 
From the calculation of ARP and Pareto diagram obtained 
two priority risk agents that contribute to 80% of the total 
ARP which are A23 (material handling error by the operator, 
with an ARP value 1032 and cumulative percentage of 16%), 
then A14 (inadequate procedure, with an ARP value 816 and 
cumulative percentage 28%). 
D. Risk Mitigation Strategy 
The next step is designing risk mitigation strategy for 
associated risk agents that are selected from HOR1 analysis, 
then determine of the effectiveness level of each proposed 
proactive action with its associated risk agent. Then, the 
degree of difficulty (Dk) of each proactive action is 
determined. The Table 6 below presents a list of some 
proactive action, its relation score and its degree of difficulty 
(Dk). 
This study proposes some risk mitigations for two priority 
risk agent. Then, the most effective proactive actions for the 
mitigation strategy through HOR2 analysis are selected for 
recomendation. The Total Effectiveness can be calculated 
from ARP of each risk agent with its relation. Then ETDk can 
be calculated from TEk score divided to Dk. The result of 
calculation of Effectiveness to Difficulty (ETDk) described 
in Matrix HOR2 Table 7. The result shown from the highest 
priority rank of proactive action is PA1 and PA3, then 
followed by PA5, PA4 and PA2. 
IV. CONCLUSION 
Risk control strategy in cell culture process of recombinant 
protein production has been performed using the House of 
Risk method. The results obtained that there are 40 risk events 
and 31 risk agents. Based on the calculation ARP and Pareto 
Chart analysis there are two risk agents were selected to be 
designed for the strategy risk control. There are five proactive 
actions proposed for the risk mitigation strategy in cell culture 
process of recombinant protein production. Based on 
calculation of Effectiveness by Difficulty (ETDk) the priority 
rank of each proactive action was determined. The result 
shown from the highest to lowest priority rank of proactive 
action recomendation for Company X are training and 
personnel qualification  accommodated by QA Department 
periodically (PA1), changing in workflow become more 
efficient and convenient, e.g. rotation of job types (PA3) then 
followed by more detailed revision of related documents 
(PA5), changing the manual process to semi-automatic 
process gradually (PA4) and the last is additional person on 
each team as a verifier for double-checking (PA2). Further 
research can be done by considering dependency between 
risk events that may occur in the other process in the 
biopharmaceutical company. 
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